AIGH Capital Management’s Pelthos Therapeutics PTHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.38M Sell
256,012
-73,086
-22% -$1.86M 0.54% 30
2026
Q2
$9.3M Buy
+329,098
New +$8.45M 0.59% 24

Other funds holding PTHS

AIGH Capital Management's PTHS Position: Q3 2026 in Review

AIGH Capital Management reduced its Pelthos Therapeutics (PTHS) stake by 22% in Q3 2026, selling an estimated $1.86M and leaving 256,012 shares worth $5.38M. The position accounts for 0.54% of the portfolio, ranked #30.

AIGH Capital Management first reported a position in PTHS in Q2 2026 and has held it in 2 quarters since. The position peaked at $9.3M in Q2 2026. 29 funds tracked by Wall St. Rank hold PTHS as of Q3 2026.

  • AIGH Capital Management held 256,012 shares of Pelthos Therapeutics worth $5.38M as of Q3 2026.
  • AIGH Capital Management sold 73,086 Pelthos Therapeutics shares in Q3 2026, an estimated $1.86M.
  • Pelthos Therapeutics made up 0.54% of AIGH Capital Management's portfolio in Q3 2026, its #30 holding.
  • AIGH Capital Management first reported a position in Pelthos Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • AIGH Capital Management's Pelthos Therapeutics position peaked at $9.3M in Q2 2026.
  • 29 funds tracked by Wall St. Rank held Pelthos Therapeutics as of Q3 2026.

Based on AIGH Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.